The Antidepressant Effect of Targeted Release of Ketamine-Loaded Nanodroplets Stimulated by Low-Intensity Focused Ultrasound
Pharmaceutics · 24.09.2025 · 17 (10) · 1251
DOI: 10.3390/pharmaceutics17101251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 24.09.2025. Verfasst von Bailing Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Project of the Basic Research Program of the Yunnan Provincial Department of Science and Technology, Yunnan Provincial Department of Science and Technology.
Abstract (Originalsprache)
Objectives
Ketamine has demonstrated rapid and sustained antidepressant effects; however, its clinical utility is limited by the risk of addiction and systemic side effects. This study aimed to develop ketamine-loaded nanodroplets (Ket-NDs) with high encapsulation efficiency (EE) and stability for targeted low-dose intravenous (IV) administration in a mice model of depression. Low-intensity focused ultrasound (LIFU) was employed to induce transcranial, region-specific drug release in the lateral habenula (LHb).
Methods
Ket-NDs were synthesized using a thin-film hydration method with sonication and emulsification, incorporating perfluoropentane as the core material. Characterization was performed using light microscopy, cryogenic scanning electron microscopy (cryo-SEM), transmission electron microscopy, and dynamic light scattering (DLS). Drug EE and loading efficiency (LE) were quantified by reversed-phase high-performance liquid chromatography. A chronic restraint stress model was established, and Ket-NDs were administered intravenously followed by LIFU targeting the LHb. Antidepressant efficacy and biosafety were systematically evaluated.
Results
(1) Ket-NDs exhibited uniform spherical morphology and a narrow size distribution, as confirmed by DLS (particle size: 139.75 ± 9.43 nm; Polydispersity index: 0.225 ± 0.025) and cryo-SEM analysis (number-average diameter: 109.5 ± 10.4 nm). The zeta potential was −15.93 ± 5.906 mV, and the formulation remained stable under 4 °C storage. (2) Ket-NDs demonstrated high EE (78.25 ± 16.13%) and LE (15.55 ± 4.49%). (3) In depressive mice, IV administration of Ket-NDs followed by LIFU targeting the LHb significantly improved behavioral outcomes: increased locomotor activity in the open field test, elevated sucrose preference index, and reduced immobility time in the tail suspension test. (4) Safety assessments revealed no significant organ toxicity or brain tissue damage in ultrasound-exposed regions.
Conclusions
In summary, this study developed stable Ket-NDs. When combined with LIFU, they enable precise regional drug delivery to the brain, showcasing a promising treatment strategy for depression with reduced systemic side effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Kunming Medical University, Kunming 650032, China.
ORCID-Profile: Bailing Wu, Mei Zhu
Förderung
- the Key Project of the Basic Research Program of the Yunnan Provincial Department of Science and Technology
- Yunnan Provincial Department of Science and Technology
Zitieren
APA
Wu, B., Xu, Y., Xie, Y., Li, Y., Huang, Y., Feng, Y., & Zhu, M. (2025). The Antidepressant Effect of Targeted Release of Ketamine-Loaded Nanodroplets Stimulated by Low-Intensity Focused Ultrasound. Pharmaceutics, 17(10), 1251. https://doi.org/10.3390/pharmaceutics17101251
Vancouver
Wu B, Xu Y, Xie Y, Li Y, Huang Y, Feng Y, et al. The Antidepressant Effect of Targeted Release of Ketamine-Loaded Nanodroplets Stimulated by Low-Intensity Focused Ultrasound. Pharmaceutics. 2025;17(10):1251. doi:10.3390/pharmaceutics17101251
BibTeX
@article{Wu2025,
author = {Wu, Bailing and Xu, Yu and Xie, Yuhang and Li, Youzhuo and Huang, Yue and Feng, Yuran and Zhu, Mei},
title = {The Antidepressant Effect of Targeted Release of Ketamine-Loaded Nanodroplets Stimulated by Low-Intensity Focused Ultrasound},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {10},
pages = {1251},
doi = {10.3390/pharmaceutics17101251}
}
EUVIMED